Clinical Trials
2 trialsNCT06587451 2026-02-24
Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®
Sandoz
Phase 3 Terminated
NCT02296398 2016-03-11
Long-term Use of Romidepsin in Patients With CTCL
Northwestern University
Completed